|
| Home : MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company's First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound |
|
Jul 13
2021 |
MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company's First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound |
|
The company's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug, ibogaine. VANCOUVER, BC, July 13, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH)... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/mindcure-announces-filing-of-us-provisional-patent-applications-for-companys-first-fully-synthetic-routes-to-create-an-ibogaine-psychedelic-compound-301332111.html |
| |
|
Related News
|
» Leapwork announces appointment of Beatrice Askaner as CMO
» BOC Group Pushes the ADONIS Experience Further With ADONIS 12.0
|
|
|
